Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Isbell

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Cell Reports. Medicine|October 16, 2024
Modeling lung adenocarcinoma metastases using patient-derived organoidsYuan Liu, Manendra Lankadasari, Joel Rosiene, et al.
JAMA|June 1, 2026
Adjuvant Nivolumab vs Observation in Resected Non-Small Cell Lung Cancer: A Randomized Clinical TrialJamie E Chaft, Zhuoxin Sun, Charles M Rudin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 18, 2024
A Real-World Assessment of Stage I Lung Cancer Through Electronic Nose TechnologyGaetano Rocco, Giorgio Pennazza, Kay See Tan, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2021
Corrigendum to "Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions" [Lung Cancer 159 (2021) 66-73]Sebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2024
Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancerSi-Yang Liu, Tatiana Erazo, Justin Jee, et al.
Lung Cancer (Amsterdam, Netherlands)|July 26, 2021
Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusionsSebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
Nature Biotechnology|April 1, 2022
Inferring gene expression from cell-free DNA fragmentation profilesMohammad Shahrokh Esfahani, Emily G Hamilton, Mahya Mehrmohamadi, et al.
Frontiers in Oncology|October 5, 2023
ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapyEmily S Lebow, Narek Shaverdian, Jordan E Eichholz, et al.
Cancer Research|December 14, 2018
Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non-Small Cell Lung CancerValsamo Anagnostou, Patrick M Forde, James R White, et al.
Journal of the National Cancer Institute|November 30, 2018
A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung CancersJoshua K Sabari, Michael Offin, Dennis Stephens, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Cell Reports. Medicine|October 16, 2024
Modeling lung adenocarcinoma metastases using patient-derived organoidsYuan Liu, Manendra Lankadasari, Joel Rosiene, et al.
JAMA|June 1, 2026
Adjuvant Nivolumab vs Observation in Resected Non-Small Cell Lung Cancer: A Randomized Clinical TrialJamie E Chaft, Zhuoxin Sun, Charles M Rudin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 18, 2024
A Real-World Assessment of Stage I Lung Cancer Through Electronic Nose TechnologyGaetano Rocco, Giorgio Pennazza, Kay See Tan, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2021
Corrigendum to "Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions" [Lung Cancer 159 (2021) 66-73]Sebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2024
Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancerSi-Yang Liu, Tatiana Erazo, Justin Jee, et al.
Lung Cancer (Amsterdam, Netherlands)|July 26, 2021
Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusionsSebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
Nature Biotechnology|April 1, 2022
Inferring gene expression from cell-free DNA fragmentation profilesMohammad Shahrokh Esfahani, Emily G Hamilton, Mahya Mehrmohamadi, et al.
Frontiers in Oncology|October 5, 2023
ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapyEmily S Lebow, Narek Shaverdian, Jordan E Eichholz, et al.
Cancer Research|December 14, 2018
Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non-Small Cell Lung CancerValsamo Anagnostou, Patrick M Forde, James R White, et al.
Journal of the National Cancer Institute|November 30, 2018
A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung CancersJoshua K Sabari, Michael Offin, Dennis Stephens, et al.
Pageof 13